BridgeMD
New treatment option for Psoriatic Arthritis
Official title Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
ClinicalTrials.gov ID: NCT06865105
What this study is testing
What is Lutikizumab?
Lutikizumab is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for psoriatic arthritis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Psoriatic arthritis (PsA) is a type of arthritis that happens when the body's immune system attacks healthy cells and tissues causing joint pain, stiffness, and swelling. Symptoms can get worse and go away for periods of time.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participant is willing and able to comply with procedures required in the Master Protocol and substudies.
- Participant has a documented clinical diagnosis of PsA with symptom onset at least 6 months prior to the Screening Visit and fulfillment of the...
- Participant has active disease defined as greater than or equal to 3 tender joints (based on 68 joint count) and greater than or equal to 3 swollen...
- Participant has active plaque PsO and/or a documented history of plaque PsO.
- Participant must demonstrate intolerance or inadequate response to 1 to 2 targeted therapies (biologic or targeted synthetic disease-modifying...
You likely can't join if
- Participants who have had major surgery performed within 12 weeks prior to randomization or plan to have a major surgery during conduct of the study...
- Participants with the following chronic or active infections: Are infected with human immunodeficiency virus (HIV), active hepatitis B virus (HBV) or...
- Active skin disease other than psoriasis (PsO) which could interfere with the assessment of PsO.
- History of fibromyalgia, any arthritis with onset prior to age 17 years, or current diagnosis of inflammatory joint disease other than psoriatic...
The study team makes the final eligibility decision.
Where it's taking place
- Huntington Beach, California, United States
- Avon Park, Florida, United States
- Clearwater, Florida, United States
- Orlando, Florida, United States
- Tamarac, Florida, United States
- Tampa, Florida, United States
- Skokie, Illinois, United States
- Willowbrook, Illinois, United States
- Hagerstown, Maryland, United States
- Middleburg Heights, Ohio, United States
- Duncansville, Pennsylvania, United States
- Memphis, Tennessee, United States
- Austin, Texas, United States
- Houston, Texas, United States
- San Antonio, Texas, United States
- Tomball, Texas, United States
- Trois-Rivières, Quebec, Canada
- Saskatoon, Saskatchewan, Canada
- Brno, Brno-mesto, Czechia
- Hlučín, Moravian-Silesian Region, Czechia
+ 16 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Huntington Beach, California, United States; Avon Park, Florida, United States; Clearwater, Florida, United States; Orlando, Florida, United States; Tamarac, Florida, United States; Tampa, Florida, United States and 30 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.